Labetalol-induced fibrosing lung disease;PNEUMOPATHIE FIBROSANTE INDUITE PAR LE LABETALOL

Revue de Pneumologie Clinique

Volumn 52, Issue 1, 1996, Pages 33-35

  Kheir, A ^a   Chabot, F ^b   Delorme, N ^b   Polu, J M ^b  

^a Service Medecine Interne   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

beta blockers; drug induced lung diseases; interstitial pneumonitis; labetalol

Indexed keywords

LABETALOL;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HYPERTENSION; LUNG LAVAGE; THORAX RADIOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; AGED; FEMALE; HUMANS; LABETALOL; PULMONARY FIBROSIS;

EID: 0029987945     PISSN: 00325821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Davies P. D. O. : Pneumonitis induced by anti-angina agents, in : Akoun G. M., White J. P. Editors. Treatment-induced respiratory disorders, Elsevier Amsterdam, 1989. pp. 125-131.
2. Lombard J. N., Bonnette B., Maynadie M., Foucher P., Reybet Degat O., Jeanin L., Camus Ph. : Celiprolol pneumonitis. Eur. Respir. J., 1993, 6, 588-591.
3. Vacher D., Aumaitre O., Mignot P., Lavarenne J., Molina C. Alvéolite allergique médicamenteuse et syndrome de Parsonage et Turner chez un malade traité par labétalol, Presse Med., 1987, 16, 539-540.
4. White D. A., Rankin J. A., Stover D. E., Gellene R. A., Gupta S. : Methotrexate pneumonitis, Am. Rev. Respir. Dis., 1989, 139, 18-21.
5. Moss J., Berg R. A., Baum B. J., Crystal R. G. : In vitro model for fibrosis induced by β-adrenergic blockers : Propanolol inhibits β-adrenergic suppression of collagen production by human fibroblasts. Clin. Res., 1979, 27, 445A.